Dtsch Med Wochenschr 2009; 134(40): 2001-2005
DOI: 10.1055/s-0029-1237546
Aktuelle Diagnostik und Therapie | Review article
Kardiologie, Prävention
© Georg Thieme Verlag KG Stuttgart · New York

Moderne Risiko-Scores in der Kardiologie

Modern risk scores in cardiologyH. Gohlke1
  • 1Klinische Kardiologie II, Herz-Zentrum Bad Krozingen
Further Information

Publication History

eingereicht: 15.6.2009

akzeptiert: 17.9.2009

Publication Date:
23 September 2009 (online)

Literatur

  • 1 Ambler G, Omar R Z, Royston P, Kinsman R, Keogh B E, Taylor K M. Generic, simple risk stratification model for heart valve surgery.  Circulation. 2005;  112 224-231
  • 2 Assmann G, Cullen P, Schulte H. Simple Scoring Scheme for Calculating the Risk of Acute Coronary Events Based on the 10-Year Follow-Up of the Prospective Cardiovascular Münster (PROCAM) Study.  Circulation. 2002;  105 310-315
  • 3 Conroy R M, Pyörälä K, Fitzgerald A P, Sans S, Menotti A, De Backer G. et al . Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project.  Eur Heart J. 2003;  24 987-1003
  • 4 De Araujo Gonvalves P, Ferreira J, Aguiar C, Seabra-Gomes R. TIMI, PURSUIT, and GRACE risk scores: sustained prognostic value and interaction with revascularization in NSTE-ACS.  Eur Heart J. 2005;  26 865-872
  • 5 Dewey T M, Brown D, Ryan W H, Herbert M A, Prince S L, Mack M J. Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement.  J Thorac Cardiovasc Surg. 2008;  135 180-187
  • 6 Gohlke H, Albus C, Bönner G. et al .Pocket-Leitlinien: Risikoadjustierte Prävention von Herz und Kreislauferkrankungen. www.dgk.org/leitlinien. 2008
  • 7 Gotto A M. for the AFCAPS/TexCAPS Research Group . Primary prevention of acute Coronary events with Lovastatin in men and women with average Cholesterol levels. Results of AFCAPS/TexCAPS.  JAMA. 1998;  279 1615-1622
  • 8 Greving J P, Buskens E, Koffijberg H, Algra A. Cost-effectiveness of aspirin treatment in the primary prevention of cardiovascular disease events in subgroups based on age, gender, and varying cardiovascular risk.  Circulation. 2008;  117 2875-2883
  • 9 Gummert J F, Funkat A, Osswald B, Beckmann A, Schiller W, Krian A, Beyersdorf F, Haverich A, Cremer J. Euro-SCORE overestimates the risk of cardiac surgery: results from the national registry of the German Society of Thoracic and Cardiovascular Surgery.  Clin Res Cardiol. 2009 March 5. [Epub ahead of print]; 
  • 10 Heidrich J, Wellmann J, Hense H -W. et al . Klassische Risikofaktoren für Herzinfarkt und Gesamtsterblichkeit in der Bevölkerung. 13-Jahres-Follow-up der MONICA Augsburg-Kohortenstudie.  Z Kardiol. 2003;  92 445-454
  • 11 Hense H W, Schulte H, Löwel H, Assmann G, Keil U. Framingham risk function overestimates risk of coronary heart disease in men and women from Germany. Results from the MONICA Augsburg cohort and the PROCAM cohorts.  Eur Heart J. 2003;  24 937-945
  • 12 Keil U, Fitzgerald A P, Gohlke H, Wellmann J, Hense H -W. Risikoabschätzung tödlicher Herz-Kreislauferkrankungen – Die neuen SCORE-Deutschland-Tabellen für die Primärprävention.  Dtsch Arztebl. 2005;  102 A 1808-1812
  • 13 National Cholesterol Education Program. Adult Treatment Panel III.  JAMA. 2001;  285 2486-2495
  • 14 Roques F, Nashef S AM, Michel P. Risk factors and outcome in European cardiac surgery: analysis of the Euro-SCORE multinational database of 19 030 patients.  Eur J Card Thorac Surg. 1999;  15 816-823
  • 15 Shepherd J, Cobbe S M, Ford I, Lorimer A R, McKillop J H, Ford I. et al . West Of Scotland Coronary Prevention Study (WOSCOPS): Identification of high risk groups and comparison with other cardiovascular Intervention trials.  Lancet. 1996;  348 1339-1342
  • 16 Stamler J, Stamler R, Neaton J D. et al . Low Risk-Factor Profile and Long-term Cardiovascular and Noncardiovascular Mortality and Life Expectancy: Findings for 5 Large Cohorts of Young Adult and Middle-Aged Men and Women.  JAMA. 1999;  282 2012-2018
  • 17 Tuomilehto J, Lindstrom J, Eriksson J G. et al . Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.  N Engl J Med. 2001;  344 1343-1350
  • 18 Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F. et al, on behalf of the INTERHEART Study Investigators . Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study).  Lancet. 2004;  364 937-952
  • 19 Gohlke H, Winter M, Karoff M, Held K. CARRISMA: a new tool to improve risk stratification and guidance of patients in cardiovascular risk management in primary prevention.  Eur J Cardiovasc Prev Rehabil. 2007;  14 141-148

Prof. Dr. med. Helmut Gohlke

Chefarzt Klinische Kardiologie II, Herz-Zentrum Bad Krozingen

Südring 15

79189 Bad Krozingen

Phone: 07633/402-2151

Fax: 07633/402-2159

Email: helmut.gohlke@herzzentrum.de

    >